Related Experiment Video
Updated: May 16, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
[Management of intracerebral hemorrhage: can we still learn something?]
D Staykov1, M Köhrmann, A Unterberg
1Neurologische Klinik, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054 Erlangen, Deutschland. dimitre.staykov@uk-erlangen.de
Insights
Intracerebral hemorrhage (ICH), a severe stroke type, impacts millions globally with no definitive treatment. Ongoing research explores surgical interventions, blood pressure control, and fibrinolysis to improve outcomes for this devastating condition.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Context:
- Intracerebral hemorrhage (ICH) represents a critical subtype of stroke, characterized by high mortality and morbidity rates.
- Annually, approximately 2 million individuals worldwide are affected by ICH, underscoring its significant public health burden.
- Despite extensive research, effective therapeutic strategies for ICH remain elusive, highlighting an urgent need for clinical advancements.
Purpose:
- To summarize the current state of intracerebral hemorrhage (ICH) research and clinical trial landscape.
- To outline the challenges and progress in developing novel treatment approaches for ICH.
- To review emerging therapeutic strategies under investigation for managing ICH.
Summary:
- ICH is a devastating stroke with significant global impact and no proven treatment.
- Advances in understanding ICH pathomechanisms and clinical effects are guiding new therapeutic development.
- Current large-scale phase III clinical trials are evaluating surgical treatments, aggressive blood pressure management, and intraventricular fibrinolysis for ICH patients.
Impact:
- Improved understanding of ICH pathophysiology is crucial for developing targeted therapies.
- Clinical trials investigating surgical options, blood pressure control, and fibrinolysis aim to reduce ICH-related mortality and morbidity.
- Successful implementation of novel treatments could significantly alter the prognosis for patients suffering from intracerebral hemorrhage.
Abstract:
Intracerebral hemorrhage (ICH) is the most devastating form of stroke. It affects approximately 2 million people worldwide every year and is a major cause of mortality and morbidity. Despite the focus of intensive scientific research on ICH for decades there is still no proven treatment strategy for this disease. Advances in knowledge on the underlying pathomechanisms of ICH and the clinical impact have contributed to the development of novel treatment approaches. Currently, surgical treatment, aggressive blood pressure management and intraventricular fibrinolysis in patients with additional severe intraventricular hemorrhage are being investigated in large scale phase III clinical trials.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Aneurysm IV: Nursing Management
Cerebral Edema ll: Pathophysiology
Stroke: Introduction and Types
